Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Current Taxes: 2021

Historic Current Taxes for Cartesian Therapeutics (RNAC) over the last 1 years, with Dec 2021 value amounting to $601,000.

  • Cartesian Therapeutics' Current Taxes was N/A to $320,000 in Q2 2022 from the same period last year, while for Jun 2022 it was $320,000, marking a year-over-year change of. This contributed to the annual value of $601,000 for FY2021, which is N/A change from last year.
  • Latest data reveals that Cartesian Therapeutics reported Current Taxes of $601,000 as of FY2021.
  • Cartesian Therapeutics' Current Taxes' 5-year high stood at $601,000 during FY2021, with a 5-year trough of $601,000 in FY2021.
  • Its 1-year average for Current Taxes is $601,000, with a median of $601,000 in 2021.